Abstract
Bone loss is a common problem for individuals with inflammatory bowel disease. Corticosteroids play an important role in the development of osteoporosis in these patients; however, active disease and longer disease duration also appear to increase the risk of osteoporosis. Given the current burden of osteoporosis, bone mineral density is recommended.
MeSH terms
-
Adolescent
-
Adrenal Cortex Hormones / adverse effects
-
Adult
-
Bone Density*
-
Child
-
Controlled Clinical Trials as Topic
-
Cross-Sectional Studies
-
Female
-
Humans
-
Inflammatory Bowel Diseases / complications
-
Inflammatory Bowel Diseases / physiopathology*
-
Longitudinal Studies
-
Male
-
Middle Aged
-
Osteoporosis / complications
-
Osteoporosis / physiopathology*